ORKA ORUKA THERAPEUTICS INC

Oruka Therapeutics to Present at the Jefferies Global Healthcare Conference

Oruka Therapeutics to Present at the Jefferies Global Healthcare Conference

MENLO PARK, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced a presentation at the Jefferies Global Health Care Conference in New York, NY:

Date: Wednesday, June 4th, 2025

Time: 12:50PM ET

A webcast and replay of Oruka’s presentation will be available on the Oruka investor events website at .

About Oruka Therapeutics

Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice a year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. For more information, visit and follow Oruka on LinkedIn.

Investor Contact: 

Alan Lada 

(650)-606-7911 

 



EN
21/05/2025

Underlying

ORKAORUKA THERAPEUTICS INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ORUKA THERAPEUTICS INC

 PRESS RELEASE
Free
ORKA ORUKA THERAPEUT...

Oruka Therapeutics to Present at the Jefferies Global Healthcare Confe...

Oruka Therapeutics to Present at the Jefferies Global Healthcare Conference MENLO PARK, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced a presentation at the Jefferies Global Health Care Conference in New York, NY: Date: Wednesday, June 4th, 2025Time: 12:50PM ET A webcast and replay of Oruka’s presentation will be available on the Oruka investor events website at...

21h / 24m 1 EN
Wedbush Research
  • Wedbush Research
LOGI LOGITECH INTERNATIONAL S.A.
WDC WESTERN DIGITAL CORPORATION
TOL TOLL BROTHERS INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
PSTG PURE STORAGE INC. CLASS A
PANW PALO ALTO NETWORKS INC.
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
INTC INTEL CORPORATION
AXTI AXT INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
HEAR TURTLE BEACH CORP.
HOV HOVNANIAN ENTERPRISES INC. CLASS A
SMCI SUPER MICRO COMPUTER
CRSR INC.
STX CORSAIR GAMING
ORKA SEAGATE TECHNOLOGY HLDGS PLC
ORUKA THERAPEUTICS INC
05/21/25 May 21, 2025 1 EN
David Nierengarten ... (+3)
  • David Nierengarten
  • Dennis Pak
  • Martin Fan
ORKA ORUKA THERAPEUTICS INC
05/21/25 May 21, 2025 1 EN
 PRESS RELEASE
Free
ORKA ORUKA THERAPEUT...

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial...

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody Pharmacokinetic and safety data from healthy volunteers anticipated around YE 2025 On track to initiate a Phase 2 study in 1H 2026 ORKA-002 preclinical data demonstrate the potential for dosing two to three times per year in psoriasis, a significant improvement over standard of care MENLO PARK, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a...

May 20, 2025 1 EN
Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
TSLA TESLA INC
TOL TOLL BROTHERS INC.
SBRA SABRA HEALTH CARE REIT INC.
OHI OMEGA HEALTHCARE INVESTORS INC.
OFC CORPORATE OFFICE PROPERTIES TRUST
NVDA NVIDIA CORPORATION
NHI NATIONAL HEALTH INVESTORS INC.
LTC LTC PROPERTIES INC.
WELL WELLTOWER INC.
GOOGL ALPHABET INC. CLASS A
CTRE CARETRUST REIT INC
ARE ALEXANDRIA REAL ESTATE EQUITIES INC.
BLDR BUILDERS FIRSTSOURCE INC.
ARGX ARGENX ADS
VTR VENTAS INC.
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
GM GENERAL MOTORS COMPANY
AAPL APPLE INC.
TSEM TOWER SEMICONDUCTOR LTD
HOV HOVNANIAN ENTERPRISES INC. CLASS A
PEAK HEALTHPEAK PROPERTIES INC.
ZNTL ZENTALIS PHARMACEUTICALS
HR HEALTHCARE TRUST OF AMERICA INC.
STRW STRAWBERRY FIELDS REIT INC.
ANRO ALTO NEUROSCIENCE INC
ORKA ORUKA THERAPEUTICS INC
JBIO JADE BIOSCIENCES INC
05/15/25 May 15, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch